SEC Form 4 · accession 0001209191-17-039154
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W. Hesslein
Officer — SVP and General Counsel
Period of report
Jun 8, 2017
Accepted (ET)
Jun 12, 2017 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2017 | M | 4,689 | $4.16 | A | 123,119 | D | |
| Common Stock | Jun 8, 2017 | M | 2,344 | $7.12 | A | 125,463 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.16 | Jun 8, 2017 | M | 4,689 | D | — | Mar 7, 2023 | Common Stock | 4,689 | 0 | D |
| Stock Option (right to buy)F2 | $7.12 | Jun 8, 2017 | M | 2,344 | D | — | May 21, 2023 | Common Stock | 2,344 | 2,344 | D |
Explanation of responses
- F1This option was granted on March 7, 2013 and vests in equal quarterly installments over a four-year period beginning on June 7, 2013.
- F2This option was granted on May 21, 2013 and vests in equal quarterly installments over a four-year period beginning on April 1, 2014.